
BOURSSOLE Newsroom
Stay ahead of the market with our curated AI-powered financial news and expert analysis.

Laprophan's Amanys Pharma Plans Major Production Shift and $37M Injectable Plant Investment
Laprophan is orchestrating a strategic reorganization of its pharmaceutical operations through its wholly-owned subsidiary Amanys Pharma. The company plans to gradually relocate antibiotic and injectable production from Casablanca to its Aïn El Aouda complex between 2027 and 2029, requiring an inves...

Laprophan's Mega IPO: A Massive Funding Boost for Growth
Laprophan is set to launch one of the largest pharmaceutical IPOs in Morocco, raising 2.22 billion dirhams with 1.4 billion in fresh capital. The proc...

LAPROPHAN IPO Guide: Everything Investors Need to Know Before the Casablanca Stock Exchange Debut
Moroccan pharmaceutical giant LAPROPHAN is preparing to list on the Casablanca Stock Exchange's Main Compartment "A" in an offering that could reach 2...

Laprophan Receives AMMC Approval for Casablanca IPO to Fund Expansion
Laprophan has secured the AMMC’s green light for a public offering on the Casablanca Stock Exchange, aiming to raise up to MAD 2.22 billion. The IPO c...

Morocco's Laprophan Expands Pharma Empire with Polymedic Acquisition Deal
Moroccan pharmaceutical giant Laprophan has signed a definitive agreement to acquire 100% of Corporate Investment Holding (CIH), the parent company...
